Abstract
Systemic lupus erythematosus is clinically characterized by episodes of flare and remission. In patients, cutaneous exposure to ultraviolet light has been proposed as a flare trigger. However, induction of flare secondary to cutaneous exposure has been difficult to emulate in many murine lupus models. Here, we describe a system in which epidermal injury is able to trigger the development of a lupus nephritis flare in New Zealand Mixed (NZM) 2328 mice. 20-week old NZM2328 female mice underwent removal of the stratum corneum via duct tape, which resulted in rapid onset of proteinuria and death when compared to sham-stripped littermate control NZM2328 mice. This was coupled with a drop in serum C3 concentrations and dsDNA antibody levels and enhanced immune complex deposition in the glomeruli. Recruitment of CD11b+CD11c+F4/80high macrophages and CD11b+CD11c+F4/80low dendritic cells was noted prior to the onset of proteinuria in injured mice. Transcriptional changes within the kidney suggest a burst of type I IFN-mediated and inflammatory signaling which is followed by upregulation of CXCL13 following epidermal injury. Thus, we propose that tape stripping of lupus-prone NZM2328 mice is a novel model of lupus flare induction that will allow for the study of the role of cutaneous inflammation in lupus development and how crosstalk between dermal and systemic immune systems can lead to lupus flare.
Keywords: Lupus, Flare, Skin, Nephritis, Chemokines
1. INTRODUCTION
Systemic lupus erythematosus (SLE) is characterized by progressive organ damage often exacerbated by acute disease flares. Development of SLE is thought to be secondary to genetic and epigenetic predisposition which promotes autoreactive T and B cell survival following exposure to appropriate environmental stimuli (reviewed in1). Autoantibodies and autoreactive cells can be present in a quiescent state of low disease activity. However, SLE patients will experience episodes of disease flare during which inflammation of various organs results in permanent damage. Knowledge of what drives the onset of flares in a previously stable patient is poorly understood. Viral infection has been linked to exacerbation of disease activity in some patients (reviewed in2). Exposure to ultraviolet (UV) light also may exacerbate cutaneous disease3 and can accelerate lupus nephritis in certain murine models4. The mechanisms promoting flares following these triggers remain poorly understood, yet they serve as important targets for development of preventative therapies for lupus flares.
Murine lupus models have been essential to dissect disease pathogenesis. These models demonstrate an accumulation of autoantibody production and autoreactive B and T cell populations followed by eventual onset of organ damage (reviewed in5). Thus, these models represent essentially a quiescent stage of the disease until organ damage ensues. Acceleration of autoantibody production and acute glomerulonephritis via injection of IFNα-expressing adenovirus has been used as a model to study the onset of acute lupus6–8, and has been a useful tool for understanding the role of this cytokine in disease onset. Other mechanisms of disease flare have been more difficult to model in murine systems, however. UV induction of systemic disease works only in murine models with increased expression of toll-like receptor (TLR)74. Importantly, TLR7 agonist stimulation of cutaneous inflammation and glomerulonephritis in wild-type mice requires cutaneous, not systemic application9, which suggests a role for skin inflammation to promote systemic disease. Epidermal injury through removal of the stratum corneum via tape application in lupus-prone NZB/NZW F1 mice has been proposed as a valid model for the study of cutaneous lupus10. Thus, we chose to use this method of epidermal injury to study the effects of cutaneous inflammation on SLE flare in lupus prone NZM2328 mice.
2. MATERIALS AND METHODS
2.1 Mice
The University of Michigan committee on use and care of animals reviewed and approved all animal protocols for this study. NZM2328 mice were a kind gift of Dr. Chaim Jacob, University of Southern California, and were bred at the University of Michigan Breeding core. Mice were housed in specific-pathogen free housing at the University of Michigan. The NZM2328 strain was chosen as it is an excellent model for lupus nephritis in that it develops high titers of dsDNA antibodies, immune complex deposits in the kidney and is the closest congenic strain to the well-studied NZB/NZW (F1) model11. Further, this model does not spontaneously develop cutaneous disease, which allows us to study the effects of cutaneous inflammation without confounders. BALB/c mice were a kind gift from Dr. Mary O’Riordan at the University of Michigan.
2.2 Cutaneous Injury via Tape Stripping
20-week old female NZM2328 mice or 20-week old female BALB/c mice were given 1 mg buprenorphene via subcutaneous injection for analgesia followed by hair removal via shaving and application of Veet to a 3×4 cm area of dorsal skin. Urine and serum were collected and stored. The mice were anesthetized in a drop jar via isoflurane (Vet One, Fluriso) and the stratum corneum was removed by 25 applications and removal of 3M duct tape placed to the dorsal skin. Rash development and urinary protein were monitored twice a week. Sham animals were given buprenorphine followed by anesthetization via isoflurane, hair removal via shaving and application of Veet, but they did not undergo duct tape application. See Table 1 for summary of treatments and sample collection.
Table 1.
Day | Treatment | Findings |
---|---|---|
0 | Serum and urine collected | |
1 | Tape Strip or Sham treatment | Skin: Increased neutrophilic epidermal inflammation |
7 | Euthanize for day 7 time point |
Skin: epidermal hyperplasia and chronic inflammatory changes Kidney: Increased macrophage infiltration; rise in renal inflammatory gene expression |
14 | Serum and urine collected, Tape Strip or Sham treatment | |
15 | Euthanize for day 15 time point | Kidney: increased immune complex deposition, increased DC and macrophage infiltration; resolution of inflammatory gene expression but increase in CXCL13. |
30, 60 | Serum and urine collection, organ harvest at euthanasia (at the onset of proteinuria) |
Skin: in surviving mice, rash is persistent and demonstrates lymphocytic and mast cell dermal inflammation. Serum: Drop in dsDNA titers, C3 and serum DNA correlates with rapid development of proteinuria and death. Kidney: Profound renal inflammation at proteinuria onset |
2.3 Characterization of anti-double stranded DNA and C3 serum levels
Serum anti-dsDNA and C3 levels were quantified via ELISA (Alpha Diagnostic International, San Antonio, TX and Innovative Research Inc.,Novi, MI), according to manufacturer’s protocols.
2.4 Proteinuria analysis
Prior to euthanasia, urine samples were collected and assessed for microalbumin using Albuwell kits (Exocell, Philadelphia, PA) and total creatinine (Cr) using a commercial kit (Bioassay Systems, Hayward, CA). Ratios of microalbumin:Cr were calculated to estimate 24 hour urinary protein excretion.
2.5 Renal Histopathology and Immune Complex Deposition Scoring
To score glomerular inflammation (activity index) and scarring (chronicity index), kidneys perfused with 10 U/ml heparin sulfate (Sigma) in PBS were fixed in 10% formalin, paraffin embedded, and section at 3 µm thickness. Periodic Acid Schiff (PAS)-stained sections were examined and graded (JBH) in a blinded manner as previously described by us and others12,13. Briefly, a semiquantitative scoring system assessed 3 different parameters of activity (mesangial hypercellularity, crescents and endocapillary cellular infiltrate) in 30 glomeruli per mouse. Scores were defined as: 0=no involvement, 0.5=minimal involvement (<10%), 1=mild involvement (10–30%), 2=moderate involvement (31–60%), 3=severe (>60%). The activity index was generated by combining the scores for mesangial hypercellularity, crescents, and endocapillary cellularity for each glomerulus and calculating the average for each mouse. The chronicity index was likewise generated by combining the scores for mesangial sclerosis, capillary sclerosis, and organized crescents and calculating the average for each mouse.
Glomerular immune complex deposition was quantified on 6µm frozen kidney sections via staining for C3 and IgG deposition as previously described13. Briefly, sections were stained with FITC-conjugated anti-C3 (ICL, Portland, OR) and Texas-red-conjugated anti-mouse IgG (Sigma) for 1 h at 4°C; Hoechst (Invitrogen, Eugene, OR) was used to visualize DNA. Immune complex staining was quantified using Metamorph v7.0. 6 glomeruli per mouse were analyzed. Integrated FITC and Texas Red staining was calculated and presented as staining per area.
2.6. Microscopy
Photomicrographs of PAS-stained renal sections and H&E stained skin sections were captured using an Olympus BX41 microscope with 40× objective. Photos of immune complex staining were captured at the Center for Live Cell Imaging (CLCI) at the University of Michigan Medical School using an Olympus IX70 inverted microscope (Olympus; Center Valley PA) and a 40× objective.
2.7 Flow Cytometry
Following euthanasia and renal perfusion as above, one whole kidney was removed for flow cytometry analysis. Tissue was minced and then digested with 0.1mg/mL Liberase (Roche), 200 U/mL DNAse (Roche) and 2.4 mM CaCl2 in DMEM (Invitrogen) at 37°C in a humidified incubator for 1 hr. Tissue was then passed through a 70µm cell strainer; RBCs were lysed with multi-species RBC lysis buffer (eBioscience) and live cells were counted via trypan blue exclusion. Cells were stained for one hour on ice using the following antibodies (all from BioLegend, San Diego, CA): CD19-PECy7, CD3-APC, Ly6G-Fitc, F4/80-PE, B220-APC, CD138-PE, CD11b-APC, CD11c-PECy7, CD11c-PE, and Ly6C-PECy7. Flow data was collected on a BD LSR II flow cytometer and analyzed via FlowJo VX.0.7 (Tree Star).
2.8 Real-time PCR
Renal tissue was homogenized in TriPur (Roche) and RNA was purified via Direct-zol mini RNA prep (Zymo). RNA (100ng) was transcribed into cDNA and quantitative real-time PCR analysis was completed on an ABI PRISM 7900HT (Applied Biosystems). Primers were as follows (all listed 5’→3’): Monocyte chemoattractant protein-1 (MCP-1) AGGTCCCTGTCATGCTTCTG (forward), GGATCATCTTGCTGGTGAAT (reverse); Absent in melanoma-2 (AIM2) CCAAACCCAGACACTATTGC (forward), TGTTCCTCCTATAGCGTTGC (reverse); Cathelicidin antimicrobial peptide (CAMP) TCAACCAGCAGTCCCTAGAC (forward), AAGGCACATTGCTCAGGTAG (reverse); Myxovirus (influenza virus) resistance 1 (Mx1) GATCCGACTTCACTTCCAGATGG (forward), CATCTCAGTGGTAGTCAACCC (reverse); Interferon alpha (IFNα common primer) ATGGCTAGRCTCTGTGCTTTCCT (forward), AGGGCTCTCCAGAYTTCTGCTCTG (reverse); Interferon beta (IFNβ) AGCTCCAAGAAAGGACGAACAT (forward), ATTCTTGCTTCGGCAGTTAC (reverse); IFN regulatory factor 7 (IRF-7) TGCTGTTTGGAGACTGGCTAT (forward), TCCAAGCTCCCGGCTAAGT (reverse); chemokine (C-C motif) receptor 1 (CCR1) TGGGCAATGTCCTAGTGATT (forward), GCATCACCAAAAATCCAGTC (reverse); IFN-inducible protein 10 (IP-10) ATCATCCCTGCGAGCCTAT (forward), ATTCTTGCTTCGGCAGTTAC (reverse); ISG15 ubiquitin-like modifier (ISG15) CAGAAGCAGACTCCTTAATTC (forward), AGACCTCATATATGTTGCTGTG (reverse); chemokine (C-C motif) ligand 4 (CCL4) AGCAACACCATGAAGCTCTG (forward), CTGTCTGCCTCTTTTGGTCA (reverse); chemokine (C-C motif) ligand 5 (CCL5) CAATCTTGCAGTCGTGTTTG (forward), GGAGTGGGAGTAGGGGATTA (reverse); IFN-γ AGCGGCTGACTGAACTCAGATTGTA (forward), GTCACAGTTTTCAGCTGTATAGGG (reverse); C-X-C motif chemokine 13 (CXCL13) AGAGGTTTGCGAGATGGACT (forward), GAGCCTGGACCTTTAAGCTG (reverse); β-Actin TGGAATCCTGTGGCATCCTGAAAC (forward), TAAAACGCAGCTCAGTAACAGTCCG (reverse); Chemokine (C-C motif) ligand 20 (CCL20) CGACTGTTGCCTCTCGTACA (forward), AGGAGGTTCACAGCCCTTTT (reverse); IL-18 ACTGTACAACCGCAGTAATACGC (forward), AGTGAACATTACAGATTTATCCC (reverse); Tumor necrosis factor alpha (TNFα) CCCACTCTGACCCCTTTACT (forward), TTTGAGTCCTTGATGGTGGT (reverse); IL-1β CCCTGCAGCTGGAGAGTGTGGA (forward), CTGAGCGACCTGTCTTGGCCG (reverse); caspase-1 GACTGGGACCCTCAAGTTTT (forward), CCAGCAGCAACTTCATTTCT (reverse); Interleukin 10 (IL-10) AGTGGAGCAGGTGAAGAGTG (forward), TTCGGAGAGAGGTACAAACG (reverse); NLRP3 ATGCTGCTTCGACATCTCCT (forward), AACCAATGCGAGATCCTGAC (reverse); IL-1 receptor antagonist (IL-1RN) GCTCATTGCTGGGTACTTACAA (forward), CCAGACTTGGCACAAGACAGG (reverse); suppressor of cytokine signaling 1 (SOCS1) CTGCGGCTTCTATTGGGGAC (forward), AAAAGGCAGTCGAAGGTCTCG (reverse); tumor growth factor β (TGFβ) CTCCCGTGGCTTCTAGTGC (forward), GCCTTAGTTTGGACAGGATCTG (reverse).. Samples were normalized to β-actin. Fold change (2−ddct) was calculated comparing tape stripped to sham injured specimens.
2.9 Statistical Analysis
All statistical analysis was completed with the use of GraphPad Prism 6.0. Comparison between groups was completed via two-tailed student’s t-test with Welch’s correction for normally distributed data and via Mann-Whitney for non-normally distributed data. Correlation analysis between serum measurements and time to onset of proteinuria was competed via linear regression. Survival analysis following tape stripping was completed via Log-rank test.
3.1. Epidermal injury results in rapid nephritis flare in lupus-prone NZM 2328 mice
At 20 weeks of age, lupus-prone NZM mice have serologic manifestations of autoimmunity such as positive ANA and anti-double-stranded DNA (dsDNA) antibodies14, but do not have evidence of active organ inflammation. Following epidermal injury via duct tape, NZM 2328 mice develop a prolonged rash which lasts up to 76 days in mice that survived for that time frame (Figure 1A). The rash is characterized by increased epidermal neutrophilic inflammation within 24 hours without the presence of inflammation in the deeper dermis. At 7 days post-injury, epidermal hyperplasia, mild dermal fibrosis and chronic inflammation are present. At euthanasia (day 69 for mouse shown), the skin demonstrates regeneration of the stratum corneum, and injured mice have developed evidence of mild dermal chronic inflammation composed of lymphocytes and fairly numerous mast cells (Figure 1B), consistent with previous reports10. During observation following skin injury, a surprising and highly significant (p=0.014) increase in profound proteinuria was noted in mice exposed to tape injury but not in sham-treated littermate controls with a median survival of 56 days post injury. A similar enhancement of proteinuria development was not seen in age and gender-matched BALB/c mice subjected to similar procedures (Figure 1C). PAS staining of kidney sections of injured NZM2328 mice at onset of 3+ proteinuria (via dipstick) or sham-treated littermates revealed enlarged, hypercellular glomeruli with inflammatory cell infiltrates and protein tubular casts only in injured mice, consistent with the onset of nephritis (Figure 1D). Similar changes were not seen in injured BALB/c mice (Figure 1D). Proteinuria was confirmed via albumin/Cr ratios and was found to rise starting 15 days after skin injury and increased significantly by 5 weeks post injury (p=0.01) (Figure 1D). No acceleration of proteinuria or nephritis was seen in 10 week old mice subjected to similar tape stripping (data not shown). Evaluation of lung, liver and cardiac pathology did not reveal evidence of organ damage or inflammation following skin injury. Further, there was no difference in white blood cell count, platelet count or hemoglobin between sham or injured animals (data not shown). These results suggest that the acceleration of nephritis was the main lupus-related phenotype following skin injury.
Many patients with SLE have elevated levels of antibodies directed against double-stranded DNA (dsDNA). NZM2328 mice also develop these antibodies and lowering of anti-dsDNA titers may correlate with tissue deposition and nephritis onset14. We thus quantified dsDNA antibody titers in our mice. As shown in Figure 2A, there was a significantly (p=0.007) lower titer of dsDNA antibodies in injured vs. sham treated NZM2328 mice 30 days after injury. Importantly, this drop in dsDNA antibody titers significantly correlated (p=0.047) with the early onset of proteinuria in injured mice (Figure 2B). Surprisingly, BALB/c mice, which had minimal levels of dsDNA antibodies at baseline, developed a significant increase (p=0.047) in dsDNA antibody titers 130 days after skin injury (Figure 2C), although levels were much less than those seen in NZM2328 mice. Complement C3 levels are also a marker of disease activity in SLE patients, as C3 will drop during acute flares and often heralds the presence of active nephritis. We measured C3 levels in our mice and noted a similar pattern to dsDNA levels, in that C3 levels dropped after skin injury and this trended (p=0.07) to correlate with the rapidity of proteinuria onset (Figures 2 D and E). No drop in C3 levels was noted in BALB/c mice (Figure 2F). Circulating DNA was also measured following skin injury, and while early detection of changes in DNA levels was not noted in pooled analysis of mice (Figure 2G), there was a highly significant (p=0.019) correlation between the drop in detectable serum DNA by day 14 and the rate in which proteinuria developed following skin injury (Figure 2H). These data suggest that immune complex formation, as characterized by drops in dsDNA antibody titers, serum C3 and serum DNA concentrations are a consequence of skin injury in NZM2328 mice.
3.2. Immune complex deposition is enhanced following cutaneous injury
In situ formation and entrapment of passively circulating immune complexes are proposed to contribute to the development of lupus nephritis (reviewed in15). Additionally, the drop in dsDNA antibodies, C3 levels and circulating serum DNA were all suggestive of immune complex formation in injured mice. Thus, we examined the deposition of immune complexes within the kidney following epidermal injury. As shown in Figure 3, mice exposed to skin injury had significant (IgG p=0.06, C3 p=0.02) increases in immune complex deposition in their kidneys by day 15 following skin injury. These results suggest that enhanced renal immune complex deposition is an early event following skin injury.
3.3. Epidermal Injury promotes dendritic cell and macrophage recruitment
As we detected the rapid onset of proteinuria and glomerular inflammation (Figure 1) subsequent to skin injury, we wanted to determine how skin injury influenced the early, pre-proteinuric, stages of renal inflammation. Mice that developed proteinuria before day 15 were excluded from analysis in order to assess pre-nephritic changes. As shown in figure 4A and 4C, renal activity scores trended towards increased inflammation but did not reach statistical significance (p=0.06) by day 15. Chronicity indices, a reflection of the duration of renal inflammation (as noted via scarring), were not affected (Figure 4B). These results suggest that while cutaneous injury results in a detectable accelerated deposition of immune complexes following skin injury, the detection of histologic inflammatory changes follows immune complex deposition.
The development of lupus nephritis has been characterized by inflammatory infiltrates of T cell (CD8>CD4), B cell, F4/80hi macrophage populations, and CD11c+CD11b+,F4/80low dendritic cells (DC)16–18. To better characterize the inflammatory changes occurring within the kidney after skin injury, prior to proteinuria onset, we examined the inflammatory cell populations in the kidneys of pre-proteinuric mice 7 and 15 days following initial skin injury to see whether skin injury promoted early recruitment of pathogenic cell populations. Gating strategies are shown in Figure S1A and B. As shown in Figure 5A, no significant changes in neutrophil populations were noted 7 or 15 days following skin injury in mice without proteinuria. This is consistent with known data in nephritic mice18. Global assessment of macrophage populations via F4/80 staining were also unchanged. T cells remained unchanged and there was a non-significant trend for increased CD19+ cells at day 15 following skin injury (Figure 5A). Early recruitment of renal CD11b+CD11c+F4/80low DCs and CD11b+CD11c+F4/80high macrophages have been described as essential for nephritis development and have been demonstrated in nephritic kidneys of several murine models of lupus18,19. By day 7 following skin injury, we detected a significant (p=0.02) increase in CD11b+CD11c+F4/80hi macrophages in the kidneys of injured mice which persisted at day 15. Detailed characterization of the macrophage and DC populations revealed no difference in plasmacytoid dendritic cell (B220+CD19−CD138+) populations. However, total DC (Ly6C+Ly6G−CD11c+) populations and CD11b+CD11c+F4/80low DCs were significantly increased by 15 days post skin injury (p=0.02 and p=0.03 respectively) (Figure 5B). Similar results were noted when absolute numbers of cells per kidney were calculated (data not shown). This suggests that recruitment of CD11b+CD11c+F4/80hi macrophages followed by CD11b+CD11c+F4/80low DCs are the first detectable significant cellular change prior to nephritis development.
In a separate analysis, mice that had developed proteinuria by day 15 following skin injury had inflammatory cell profiles consistent with known nephritic changes16,18,19 including elevations in CD11b+CD11c+F4/80hi macrophages, T cell and B cell populations (Figure S1C). These results suggest that nephritis accelerated by epidermal injury is similar to nephritis that develops as part of natural disease progression as reported by others16,18,19.
3.4. Renal interferon and inflammatory responses are increased within the kidney by day 7 post cutaneous injury and are followed by upregulation of CXCL13
As Immune complexes can promote TLR signaling within the kidney20–22, we chose to examine changes in expression of various inflammatory and chemotactic factors within the kidney 7 and 15 days following skin injury. As shown in Figure 6A and B, by day 7 following skin injury, elevation of type I IFNs and type I IFN response genes are seen and this IFN response resolves (except for IRF7 upregulation) by day 15. At day 7, a striking increase in TNFα is also noted which also resolves by day 15. Pro-inflammatory genes, including upregulation of NLRP3, an inflammasome scaffold with a role in lupus nephritis13,23,24, is also noted following cutaneous injury and this upregulation persists through day 15. Anti-inflammatory genes, with the exception of IL-10 are not upregulated at day 7 or day 15 following skin injury. Importantly, by day 15, a significant increase in CXCL13 is noted (Figure 6B). This chemokine has been identified as an early marker in both murine and human lupus nephritis25. These results suggest that cutaneous injury results in defined signaling changes within the kidney that promote type I IFN responses, inflammasome activation and upregulation of CXCL13.
4. Discussion
Here we describe a novel model of lupus flare induced by tape stripping. This epidermal injury results in removal of the stratum corneum and acute neutrophilic inflammation within the epidermis. This is followed by accelerated immune complex deposition in the kidney, recruitment of CD11b+CD11c+F4/80high and CD11b+CD11c+F4/80low DCs prior to nephritis onset, and generation of defined expression changes within the kidney which promote recruitment of and reflect known pathophysiologic changes associated with lupus nephritis. Our model does not work in pre-autoimmune NZM2328 mice, suggesting that pre-formed DNA antibodies are required for nephritis induction, thus proposing skin injury as a stressor which is able to induce the development of a nephritis flare in an otherwise “stable” lupus mouse. The timing of nephritis development in our model is similar to that reported with IFNα-driven lupus exacerbation6,8 where development of nephritis is seen within 14–42 days. Similarly, we see enhancement of early type I IFN responses and immune complex deposition within the glomeruli following cutaneous injury. However, our model has several distinctions. First, it requires pre-existing autoimmunity in that tape stripping does not accelerate disease in 10-week old mice whereas IFNα administration does6,8. Thus, our model is more reflective of the effects of cutaneous inflammation on stable lupus, and thus serves as a representation of flare. Secondly, we do not see a promotion of autoimmunity after tape stripping in NZM2328 mice as our mice show a drop in dsDNA titers, which correlates with accelerated proteinuria, rather than a rise in autoantibody production which has been reported with IFNα administration7. This is consistent with previous reports that suggest declines in anti-dsDNA titer and serum DNA levels correlate with immune complex deposition in the tissues and disease flare26,27. Epidermal injury of BALB/c mice also did not result in nephritis; intriguingly, however, it did result in an increased rise in dsDNA antibody titers in injured but not sham treated mice. This suggests there may be a role for skin injury in promoting autoimmunity in wild-type mice. This would be consistent with other work which has shown that epidermal overexpression of inflammatory cytokines like IFNγ can drive autoimmunity development28. This finding warrants further investigation.
Following epidermal injury, we are able to detect defined transcriptional changes within the kidney which support the role of immune complex mediated signaling as an initiator of renal injury. Immune complexes containing nucleosomes and anti-dsDNA antibodies have been shown to be an initiating factor for lupus nephritis21. Pathogenic mechanisms include stimulation of chemokine production from mesangial cells within the kidney21,29 as well as immune complex stimulation of dendritic and plasmacytoid dendritic cell toll-like receptors and renal macrophages22,30–32. Importantly, immune complex-mediated injury has been shown to induce recruitment of CD11c+ cells to the glomeruli within 7 days of deposition26, and our data supports this model.
Following injury, our mice develop defined transcriptional changes within the kidney. We detect a rise in type I IFN response genes within the kidney and the upregulation of IRF7 remains persistent in the pre-nephritis state. Additionally, early production of TNFα within the kidney following skin injury is consistent with reports of TNFα elevations in active lupus33. TNFα can also facilitate CD11c+ dendritic cell recruitment to the tubulointerstitial compartment of the kidney26 in a non-TNFR2 dependent manner27. In addition to TNFα, other NFκB dependent genes, such as NLRP3 are upregulated following tape stripping. The NLRP3 inflammasome is an important contributor to lupus nephritis13,23,24, and the contributions of this complex in renal inflammation should be further explored. We did not detect changes in anti-inflammatory gene expression, with the exception of IL-10, following skin injury. This may reflect the unusual behavior of IL-10 in lupus in that this gene has abnormal regulation in the presence of type I IFN34 and has been shown to be elevated in active lupus nephritis35.
Importantly, we also see evidence of defined chemokine changes within the kidney after tape stripping. Renal CCL4 transcripts are significantly increased within 7 days of tape stripping. This chemokine serves as a monocyte attractant and has been reported to attract T cells as well36. CCL4/MIP-1β has been described as elevated in murine lupus in the LPR model after the onset of nephritis has occurred37. CCL4 is upregulated downstream of TLR signaling36 and has been shown to promote type I IFN responses after immune complex stimulation of plasmacytoid dendritic cells38. Our data suggest that CCL4 may also be activated, at least transiently, within the glomeruli before nephritis onset and may thus contribute to the recruitment of CD11b+CD11c+F4/80low DCs. Further, we detect a rise in CXCL13 by day 15. CXCL13 has recently received attention for its role as a very early marker for nephritis onset25.
It is able to upregulate CXCR5 in podocytes and also upregulates the expression of the chemokines CXCL1, CXCL12, macrophage migration inhibitory factor and leukemia inhibitory factor as well as podocyte migratory factors11. The primary source of CXCL13 in nephritis is CD11b+CD11c+ dendritic cells and DC11b+CD11cint macrophages17,39, and our data suggest that the rise of CXCL13 in the kidney occurs concurrently with a rise in these cell populations. The role of CCL4 and CXCL13 in nephritis initiation will be important considerations for future studies.
In summary, we have described a novel model of lupus flare induction mediated by epidermal injury in lupus-prone NZM2328 mice. This model results in dermal and epidermal inflammation, immune complex deposition in the kidney, recruitment of CD11b+CD11c+F4/80low DCs and CD11b+CD11c+F4/80high macrophages and CXCL13 production followed by florid nephritis. Further research utilizing this model will help to determine the role of defined signaling pathways in dermal inflammation and renal disease.
Supplementary Material
Highlights.
Lupus prone NZM2328 mice subjected to tape-stripping develop accelerated nephritis
Immune complex deposition within the glomeruli is enhanced following epidermal injury
Prior to proteinuria onset, CD11b+CD11c+f4/80high macrophages and CD11b+CD11c+f4/80low DC are recruited into the kidney
CXCL13 expression is increased in the kidney following epidermal injury prior to the onset of proteinuria
ACKNOWLEGDEMENTS
This work was supported by the Arthritis National Research Foundation (to JMK), University of Michigan’s George M. O’Brien Kidney Translational Research Core Center, 2P30-DK-081943, funded by NIH/NIDDK (to JMK) and by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number K08AR063668 (to JMK). JBH received support through the NIH via PHS grant K08DK088944. SJW was supported by the research training in experimental immunology training grant under Award Number T32AI007413.
Abbreviations
- AIM2
absent in melanoma 2
- CAMP
cathelicidin antimicrobial peptide
- CCL
chemokine (c-c) ligand
- CCR
chemokine (c-c) receptor
- cxcl
chemokine (c-x-c) ligand
- IFN
interferon
- IRF
interferon regulatory factor
- MCP
monocyte chemoattractant protein
- MX
myxovirus resistance
- NZM
New Zealand Mixed
- SLE
systemic lupus erythematosus
- TLR
toll-like receptor
- TNF
tumor necrosis factor
- UV
ultraviolet
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
REFERENCES
- 1.Marion T, Postlethwaite A. Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus. Semin Immunopathol. 2014:1–23. doi: 10.1007/s00281-014-0440-x. [DOI] [PubMed] [Google Scholar]
- 2.Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus. 2014;23:596–605. doi: 10.1177/0961203314531637. [DOI] [PubMed] [Google Scholar]
- 3.Sanders CJ, et al. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol. 2003;149:131–137. doi: 10.1046/j.1365-2133.2003.05379.x. doi:5379 [pii] [DOI] [PubMed] [Google Scholar]
- 4.Ansel JC, Mountz J, Steinberg AD, DeFabo E, Green I. Effects of UV Radiation on Autoimmune Strains of Mice: Increased Mortality and Accelerated Autoimmunity in BXSB Male Mice. J Investig Dermatol. 1985;85:181–186. doi: 10.1111/1523-1747.ep12276652. [DOI] [PubMed] [Google Scholar]
- 5.Perry D, Sang A, Yin Y, Zheng YY, Morel L. Murine models of systemic lupus erythematosus. Journal of biomedicine & biotechnology. 2011;2011:271694. doi: 10.1155/2011/271694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dai C, et al. Interferon alpha on NZM2328.Lc1R27: Enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure. Clinical Immunology. 2014;154:66–71. doi: 10.1016/j.clim.2014.06.008. doi: http://dx.doi.org/10.1016/j.clim.2014.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Liu Z, et al. Interferon-alpha accelerates murine systemic lupus erythematosus in a T cell-dependent manner. Arthritis Rheum. 2011;63:219–229. doi: 10.1002/art.30087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jacob N, et al. B Cell and BAFF Dependence of IFN-α–Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice. The Journal of Immunology. 2011;186:4984–4993. doi: 10.4049/jimmunol.1000466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Yokogawa M, et al. Epicutaneous Application of Toll-like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild-Type Mice: A New Model of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2014;66:694–706. doi: 10.1002/art.38298. [DOI] [PubMed] [Google Scholar]
- 10.Guiducci C, et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J Exp Med. 2010;207:2931–2942. doi: 10.1084/jem.20101048. doi:jem.20101048 [pii] 10.1084/jem.20101048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jacob CO, et al. Pivotal Role of Stat4 and Stat6 in the Pathogenesis of the Lupus-Like Disease in the New Zealand Mixed 2328 Mice. The Journal of Immunology. 2003;171:1564–1571. doi: 10.4049/jimmunol.171.3.1564. [DOI] [PubMed] [Google Scholar]
- 12.Zhao W, et al. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J Immunol. 2009;183:2729–2740. doi: 10.4049/jimmunol.0804341. doi:jimmunol.0804341 [pii] 10.4049/jimmunol.0804341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kahlenberg JM, et al. An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage. Arthritis Rheumatol. 2014;66:152–162. doi: 10.1002/art.38225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Waters ST, et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med. 2004;199:255–264. doi: 10.1084/jem.20031519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lech M, Anders H-J. The Pathogenesis of Lupus Nephritis. Journal of the American Society of Nephrology. 2013 doi: 10.1681/ASN.2013010026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lourenço EV, Wong M, Hahn BH, Palma-Diaz MF, Skaggs BJ. Laquinimod Delays and Suppresses Nephritis in Lupus-Prone Mice and Affects Both Myeloid and Lymphoid Immune Cells. Arthritis & Rheumatology. 2014;66:674–685. doi: 10.1002/art.38259. [DOI] [PubMed] [Google Scholar]
- 17.Schiffer L, et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol. 2008;180:1938–1947. doi: 10.4049/jimmunol.180.3.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sahu R, Bethunaickan R, Singh S, Davidson A. Structure and Function of Renal Macrophages and Dendritic Cells From Lupus-Prone Mice. Arthritis & Rheumatology. 2014;66:1596–1607. doi: 10.1002/art.38410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Triantafyllopoulou A, et al. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A. 2010;107:3012–3017. doi: 10.1073/pnas.0914902107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lövgren T, et al. Induction of interferon-α by immune complexes or liposomes containing systemic lupus erythematosus autoantigen– and Sjögren's syndrome autoantigen–associated RNA. Arthritis & Rheumatism. 2006;54:1917–1927. doi: 10.1002/art.21893. [DOI] [PubMed] [Google Scholar]
- 21.Tofteland ND, Shaver TS. Clinical efficacy of etanercept for treatment of PAPA syndrome. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2010;16:244–245. doi: 10.1097/RHU.0b013e3181e969b9. [DOI] [PubMed] [Google Scholar]
- 22.Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006;6:823–835. doi: 10.1038/nri1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhao J, et al. P2X7 blockade attenuates lupus nephritis by inhibiting NLRP3/ASC/caspase-1 activation. Arthritis & Rheumatism. 2013 doi: 10.1002/art.38174. n/a-n/a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhao J, et al. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation. International Immunopharmacology. 2013;17:116–122. doi: 10.1016/j.intimp.2013.05.027. doi: http://dx.doi.org/10.1016/j.intimp.2013.05.027. [DOI] [PubMed] [Google Scholar]
- 25.Jacob CO, et al. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor. Arthritis Rheum. 2013;65:1043–1054. doi: 10.1002/art.37846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Knight JS, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Annals of the Rheumatic Diseases. 2014 doi: 10.1136/annrheumdis-2014-205365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ho A, Magder LS, Barr SG, Petri M. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2342–2349. doi: 10.1002/1529-0131(200110)44:10<2342::aid-art397>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- 28.Seery JP, Carroll JM, Cattell V, Watt FM. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med. 1997;186:1451–1459. doi: 10.1084/jem.186.9.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Menke J, et al. Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice. J Immunol. 2008;181:7367–7379. doi: 10.4049/jimmunol.181.10.7367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Shin MS, et al. U1-Small Nuclear Ribonucleoprotein Activates the NLRP3 Inflammasome in Human Monocytes. The journal of immunology. 2012;188:4769–4775. doi: 10.4049/jimmunol.1103355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Shin MS, et al. Self Double-Stranded (ds)DNA Induces IL-1β Production from Human Monocytes by Activating NLRP3 Inflammasome in the Presence of Anti–dsDNA Antibodies. The journal of immunology. 2013 doi: 10.4049/jimmunol.1201195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Tian J, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8:487–496. doi: 10.1038/ni1457. doi: http://www.nature.com/ni/journal/v8/n5/suppinfo/ni1457_S1.html. [DOI] [PubMed] [Google Scholar]
- 33.Cigni A, et al. Interleukin 1, Interleukin 6, Interleukin 10, and Tumor Necrosis Factor α in Active and Quiescent Systemic Lupus Erythematosus. Journal of Investigative Medicine. 2014;62:825–829. doi: 10.2310/JIM.0000000000000085. 810.231/JIM.0000000000000085. [DOI] [PubMed] [Google Scholar]
- 34.Cates AM, et al. Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon alpha on lupus endothelial cell progenitors. Rheumatology (Oxford, England) 2015;54:1114–1123. doi: 10.1093/rheumatology/keu431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Koenig KF, et al. Serum cytokine profile in patients with active lupus nephritis. Cytokine. 2012;60:410–416. doi: 10.1016/j.cyto.2012.07.004. doi: http://dx.doi.org/10.1016/j.cyto.2012.07.004. [DOI] [PubMed] [Google Scholar]
- 36.Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2001;2:1126–1132. doi: 10.1038/ni735. [DOI] [PubMed] [Google Scholar]
- 37.Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular cell. 2002;10:417–426. doi: 10.1016/s1097-2765(02)00599-3. [DOI] [PubMed] [Google Scholar]
- 38.Mariathasan S, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 2004;430:213–218. doi: 10.1038/nature02664. [DOI] [PubMed] [Google Scholar]
- 39.Ishikawa S, et al. Aberrant High Expression of B Lymphocyte Chemokine (Blc/Cxcl13) by C11b+Cd11c+ Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells towards Blc. The Journal of Experimental Medicine. 2001;193:1393–1402. doi: 10.1084/jem.193.12.1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.